Dr. Zachary Louis Bercu, MD

Dr. Bercu practices at Emory University Hospital in Atlanta, Georgia, part of Emory University.

Dr. Bercu's NPI, 1669795340, was assigned on March 9, 2010. Dr. Bercu graduated from Emory School of Medicine in 2009. Dr. Bercu holds Georgia license 074175.

Dr. Bercu's primary practice is Emory University Hospital, at 1364 Clifton Road, NE, Atlanta, GA 30322 in De Kalb County. The practice phone is (404) 686-8500.

Dr. Bercu's primary practice is Emory University Hospital in Atlanta, Georgia, part of Emory University. Dr. Bercu is also affiliated with Emory University Hospital Midtown. The medical group on file is Emory Clinic. Dmand AI also links Dr. Bercu to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bercu practices, 2 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Bercu's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Bercu is board certified in interventional radiology and diagnostic radiology by the American Board of Radiology. Dmand AI has Dr. Bercu's licenses on file in 2 states: Georgia and New York.

CMS data shows 17 Medicare services from Dr. Bercu across 1 procedure code in 2024, for 56 Medicare patients. Medicare paid $156 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 56 Medicare patients who saw Dr. Bercu in 2024. The largest group is 65 to 74, with 30 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 25% are also on Medicaid. Their average risk score is 3.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bercu's median patient age at 66, with 54% women.

In 2024, Dr. Bercu wrote 60 Medicare Part D claims for 19 patients. 83% of them were for generic drugs. CMS names the drug for 46 of them, across 3 drugs with 11 or more claims each, at $587 in total drug cost. In 2022, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Bercu for performance year 2024, reported through an alternative payment model (APM). Dr. Bercu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bercu as offering telehealth.

Dmand AI links 78 papers to Dr. Bercu, published from 2006 to 2025. 2020 was the busiest year, with 13. The most frequent topics are Liver Neoplasms, Yttrium Radioisotopes and Embolization, Therapeutic. Dr. Bercu has published most often in Cardiovasc Intervent Radiol. Dr. Bercu's most frequent co-authors are David Michael Schuster, MD, Ila Sethi, MD and David Charlton Brandon, MD.

CMS Open Payments shows 110 general payments to Dr. Bercu from 25 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 46% of the total. Terumo Medical Corporation paid the most, $10,697.

Dmand AI lists 13 awards for Dr. Bercu, most recently Recipient, Fellow/Resident Activity Honorarium in 2014.

Dr. Bercu graduated from Emory School of Medicine in 2009. Dr. Bercu is a member of ACR, RSNA and SIR.

Dr. Bercu is in network with 8 carriers, including Blue Cross Blue Shield of Michigan, Cigna and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.